Vir Biotechnology Inc. VIR reported better-than-expected fourth-quarter earnings, anounced a significant strategic ...

Experts discuss biotechnology's role in advancing personalized medicine at a VIT webinar, highlighting career opportunities ...

Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for cancer, today announced that the U.S. Food and Drug ...

Unnatural Products, a biotech company founded by UC Santa Cruz alumni Cameron Pye (Ph.D. ’17, chemistry & biochemistry) and ...

Carnegie Mellon University and the University of Pittsburgh offered rare looks Thursday into two cutting-edge research ...

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...

The consensus estimate for Q4 2025 revenue is $23.18 million, and the earnings are expected to come in at -$0.41 per share. The full year 2025's revenue is expected to be $19.22 million, and the ...

Apogee Therapeutics (NASDAQ: APGE) is one of the 17 biotechnology stocks with more than 50% upside. On January 25, Citi analyst Geoff Meacham maintained a Buy rating on Apogee Therapeutics ...

Do you want to be at the forefront of the rapidly growing biotechnology field? Do you want to develop products derived from living organisms and biomolecules? Do you have a passion for biochemistry, ...

The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on June 19, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of ...

The Department of Biotechnology, under the Ministry of Science and Technology has released notification for the Scientist 'C' posts.